Advertisement

Pharmaceutisch Weekblad

, Volume 2, Issue 1, pp 642–647 | Cite as

Biochemistry of Prostaglandins

  • R. Maier
Prostaglandines

Summary

Prostaglandins are ubiquitous compounds being biosynthetised in most cells from essential fatty acids composed of twenty carbon atoms. They are, however, not responsible for the essential character of these fatty acids.

The nomenclature of the prostaglandins is derived from the precursors denoting the suffixes of the series 1, 2 and 3. Within a series the compounds are held apart by letters according to the kind and stereochemical positioning of the oxygen substituent on the cyclopentane ring.

The biosynthesis from the precursors proceeds via peroxides catalysed by a number of enzymes, which are globally known as prostaglandin synthetase. The best known of these enzymes is the cyclo-oxygenase being inhibited by nonsteroidal anti-inflammatory drugs.

Chemical synthesis has been achieved by several groups, particularly in order to develop more stable compounds. Catabolic degradation is rapid and leads to dicarboxylic acids being eliminated in the urine.

Keywords

Oxygen Public Health Peroxide Internal Medicine Carbon Atom 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bergström, S., H. Danielsson, D. Klenberg andB. Samuelsson (1964)J. Biol. Chem. 239, 4006.Google Scholar
  2. Corey, E. J. (1969) In:Proc. of the R. A. Welsh Found. Conf. on Chem. Res. xiiOrg. Syn. (Milligan, W. O., Ed.) Houston, Texas, 51.Google Scholar
  3. Dorp, D. A. van, R. K. Beerthuis, D. H. Nugteren andH. Vonkeman (1964)Nature 203, 839–843.Google Scholar
  4. Euler, U. S. von (1938)J. Physiol. (London)93, 129–143.Google Scholar
  5. Goldblatt, M. W. (1935)J Physiol. (London)90, 208–218.Google Scholar
  6. Gryglewsky, R. J., P. Bogumila, R. Korbut, L. Grodzinska andA. Ocetkiewiez (1975)Prostaglandins 10, 343–355.Google Scholar
  7. Kuehl, F. A., J. L. Humes, R. W. Egan, E. A. Ham, G. C. Beveridge andG. von Armen (1977)Nature 265, 170–173.Google Scholar
  8. Lewis, G. P., P. J. Piper andC. Vigo (1979)Brit. J. Pharmacol. 67, 393–400.Google Scholar
  9. Murphy, R. C., S. Hammerström andB. Samuelsson (1979)Proc. Nat. Acad. Sci. USA 76, 4275–4279.Google Scholar
  10. Saeed, S. A., andA. C. Roy (1972)Biochem. Biophys. Res. Commun. 47, 96–102.Google Scholar
  11. Samuelsson, B., E. Granström, K. Green andM. Hamberg (1971) In:Prostaglandins (Ramwell, P., andJ. E. Shaw, Eds.) N.Y. Acad. Sci., 138.Google Scholar
  12. Smith, J. B., andA. L. Wills (1971)Nature (New Biol.) 231, 235–237.Google Scholar
  13. Vane, J. R. (1971)Nature (New Biol.) 231, 232–235.Google Scholar
  14. Woodward, R. B., J. Gosteli, I. Ernest, P. J. Friary, G. Nestler, H. Raman, R. Sitrin, Ch. Suter andJ. K. Whitesell (1973)J. Am. Chem. Soc. 95, 6853–6855.Google Scholar

Copyright information

© Bohn, Scheltema & Holkema 1980

Authors and Affiliations

  • R. Maier
    • 1
  1. 1.Ciba-Geigy AGBasleSwitzerland

Personalised recommendations